Cost analysis of the use of botulinum toxin type A in Spain

Cost analysis of the use of botulinum toxin type A in Spain

Objective: To estimate treatment costs of blepharospasm, cervical dystonia(CD), upper limb spasticity (ULS) and spasticity in children withcerebral palsy (SCCP) with botulinum neurotoxin type A (BoNT-A) inSpain. Method: Annual BoNT-A treatment costs were calculated (2013 ex-factoryprice () applyin...

Full description

Bibliographic Details
Main Authors: F. de Andrés-Nogales, A. Morell, J. Aracil, C. Torres, I. Oyagüez, M. A. Casado
Format: Article
Language:English
Published: Grupo Aula Médica 2014-05-01
Series:Farmacia Hospitalaria
Subjects:
Cost analysis
Botulinic toxin A
Blepharospasm
Adult arm spasticity.
Cerebral palsy-induced pediatric
Cervical dystonia
Spain
Online Access:http://www.aulamedica.es/fh/pdf/1163.pdf

Internet

http://www.aulamedica.es/fh/pdf/1163.pdf

Similar Items